Advertisement
ABCL vs TLSA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and TLSA is a Hold.
ABCL in downward trend: price may decline as a result of having broken its higher Bollinger Band on September 29, 2026
ABCL broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In 37 of the 40 cases the stock fell afterwards. This puts the odds of success at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for ABCL moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 25 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABCL as a result. In 75 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for ABCL turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 33 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
ABCL moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABCL advanced for three days, in 204 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 128 of 165 cases where ABCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.427) is normal, around the industry mean (2.988). P/E Ratio (-22.667) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (53.191) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ABCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
TLSA's RSI Indicator recovers from oversold territory
The RSI Oscillator for TLSA moved out of oversold territory on September 17, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 22 of the 26 cases the stock moved higher. This puts the odds of a move higher at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for TLSA crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 70%.
Following a +8.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLSA advanced for three days, in 204 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 77 of 100 cases where TLSA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TLSA as a result. In 92 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for TLSA turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In 55 of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
TLSA moved below its 50-day moving average on October 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLSA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. TLSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (23.217) is normal, around the industry mean (2.988). P/E Ratio (-5.941) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLSA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ABCL | TLSA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 70 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 99 | |
PRICE GROWTH RATING 1..100 | 34 | 57 | |
P/E GROWTH RATING 1..100 | 97 | 39 | |
SEASONALITY SCORE 1..100 | n/a | 33 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ABCL's Valuation (9) in the null industry is significantly better than the same rating for TLSA (86) in the Biotechnology industry. This means that ABCL’s stock grew significantly faster than TLSA’s over the last 12 months.
ABCL's Profit vs Risk Rating (100) in the null industry is in the same range as TLSA (100) in the Biotechnology industry. This means that ABCL’s stock grew similarly to TLSA’s over the last 12 months.
ABCL's SMR Rating (94) in the null industry is in the same range as TLSA (99) in the Biotechnology industry. This means that ABCL’s stock grew similarly to TLSA’s over the last 12 months.
ABCL's Price Growth Rating (34) in the null industry is in the same range as TLSA (57) in the Biotechnology industry. This means that ABCL’s stock grew similarly to TLSA’s over the last 12 months.
TLSA's P/E Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for ABCL (97) in the null industry. This means that TLSA’s stock grew somewhat faster than ABCL’s over the last 12 months.
| ABCL | TLSA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 4 days ago 85% |
| Stochastic ODDS (%) | 2 days ago 80% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 81% |
| Advances ODDS (%) | 11 days ago 81% | 14 days ago 84% |
| Declines ODDS (%) | 9 days ago 82% | 18 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | N/A |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 77% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABCL’s FA Score shows that 1 FA rating(s) are green while TLSA’s FA Score has 0 green FA rating(s).
- ABCL’s FA Score: 1 green, 4 red.
- TLSA’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABCL’s TA Score shows that 4 TA indicator(s) are bullish while TLSA’s TA Score has 5 bullish TA indicator(s).
- ABCL’s TA Score: 4 bullish, 5 bearish.
- TLSA’s TA Score: 5 bullish, 4 bearish.
Price Growth
ABCL (@Biotechnology) experienced а -1.05% price change this week, while TLSA (@Biotechnology) price change was -3.81% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.04%. For the same industry, the average monthly price growth was -18.13%, and the average quarterly price growth was -15.32%.
Reported Earning Dates
ABCL is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Biotechnology (-1.04% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ABCL and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.
| Ticker / NAME | Correlation To ABCL | 1D Price Change % | ||
|---|---|---|---|---|
| ABCL | 100% | +4.53% | ||
| RXRX - ABCL | 57% Loosely correlated | -0.55% | ||
| CRSP - ABCL | 56% Loosely correlated | +1.24% | ||
| ABSI - ABCL | 56% Loosely correlated | +10.69% | ||
| VCYT - ABCL | 56% Loosely correlated | +3.19% | ||
| AXON - ABCL | 51% Loosely correlated | +2.54% | ||
More | ||||
TLSA and
Correlation & Price change
A.I.dvisor indicates that over the last year, TLSA has been loosely correlated with JAGX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TLSA jumps, then JAGX could also see price increases.
| Ticker / NAME | Correlation To TLSA | 1D Price Change % | ||
|---|---|---|---|---|
| TLSA | 100% | N/A | ||
| JAGX - TLSA | 36% Loosely correlated | -13.31% | ||
| IMVT - TLSA | 26% Poorly correlated | -0.73% | ||
| ABCL - TLSA | 25% Poorly correlated | +4.53% | ||
| MGX - TLSA | 25% Poorly correlated | -0.30% | ||
| DNA - TLSA | 25% Poorly correlated | +1.52% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AMKL | 4.49 | 0.40 | +9.78% |
| Defiance Daily Target 2X Long AMKR ETF (AMKL) | |||
| AIFD | 50.57 | 0.96 | +1.93% |
| TCW Artificial Intelligence ETF (AIFD) | |||
| PABU | 79.68 | 0.54 | +0.68% |
| iShares Paris-Aligned Climate Optimized MSCI USA ETF (PABU) | |||
| THEQ | 30.50 | 0.15 | +0.50% |
| T. Rowe Price Hedged Equity ETF | |||
| GXC | 82.99 | -1.13 | -1.35% |
| State Street SPDR S&P China ETF (GXC) | |||